awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30240043-076A4128-1090-4546-B9F9-4134C4D8C377
Q30240043-076A4128-1090-4546-B9F9-4134C4D8C377
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30240043-076A4128-1090-4546-B9F9-4134C4D8C377
How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changes.
P2860
Q30240043-076A4128-1090-4546-B9F9-4134C4D8C377
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30240043-076A4128-1090-4546-B9F9-4134C4D8C377
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d437db8a3a319eba3e378a55677e52f8aef3ed0a
P2860
X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies